McKesson
MCK
#250
Rank
NZ$157.94 B
Marketcap
NZ$1,349
Share price
0.72%
Change (1 day)
12.99%
Change (1 year)
McKesson Corporation is an American company distributing pharmaceuticals and providing health information technology, medical supplies, and care management tools.

EPS for McKesson (MCK)

EPS in 2025 (TTM): NZ$60.12

According to McKesson's latest financial reports the company's current EPS (TTM) is NZ$59.98. an increase over its 2024 EPS that were of NZ$37.72.

EPS history for McKesson from 2014 to 2025

Annual EPS

Year EPS Change
2025NZ$59.7258.33%
2024NZ$37.72-1.17%
2023NZ$38.171%
2022NZ$37.79144.72%
2021NZ$15.44-133.49%
2020NZ-$46.10451.13%
2019NZ-$8.36266.17%
2018NZ-$2.28-105.85%
2017NZ$39.06166.28%
2016NZ$14.670.71%
2015NZ$14.5714.44%
2014NZ$12.73

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Cerner
CERN
NZ$3.44-94.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Henry Schein
HSIC
NZ$5.74-90.44%๐Ÿ‡บ๐Ÿ‡ธ USA
AmerisourceBergen
ABC
NZ$14.24-76.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Cardinal Health
CAH
NZ$11.28-81.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Premier
PINC
NZ-$0.46-100.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Patterson Companies
PDCO
NZ$2.68-95.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Computer Programs and Systems
CPSI
NZ-$5.41-109.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Veradigm
MDRX
NZ$0.86-98.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Owens & Minor
OMI
NZ-$29.89-149.84%๐Ÿ‡บ๐Ÿ‡ธ USA